Using virtual reality, investigators found that women with eating disorders paid more attention to weight-related areas of an avatar’s body, while their male counterparts paid more attention to non-weight-related body parts.
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for dasotraline (Sunovion) in the treatment of binge eating disorder.
Early warning signs may help providers identify eating disorders earlier.
Disordered eating to bulk up is common among young men and may be a warning sign of future health problems.
Women with eating disorders experience persistently greater depressive symptoms across the life-course.
One in five patients with adolescent-onset anorexia nervosa have a chronic eating disorder 30 years later.
Eating disorders are highly prevalent worldwide, especially among women.
Infections that require hospitalization and treatment with anti-infective agents in childhood are associated with an increased risk for eating disorders in adolescent girls.
Phenotypes such as impaired social cognition and irritability could represent risk factors for both schizophrenia and binge eating behaviors.
Individuals who tend to experience negative affect and diabetes distress before eating are at increased risk for objective binge eating at an upcoming meal.
